相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
Laura A. VanBlargan et al.
NATURE MEDICINE (2022)
Omicron variant and booster COVID-19 vaccines
Talha Khan Burki
LANCET RESPIRATORY MEDICINE (2022)
COVID-19 diagnosis - A review of current methods
Meral Yuce et al.
BIOSENSORS & BIOELECTRONICS (2021)
The potential impact of the COVID-19 pandemic on child growth and development: a systematic review
Liubiana Arantes de Araujo et al.
JORNAL DE PEDIATRIA (2021)
Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine
Bilal Malik et al.
BMJ CASE REPORTS (2021)
Guillain-Barre syndrome after COVID-19 vaccination
Norma McKean et al.
BMJ CASE REPORTS (2021)
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Robert L. Gottlieb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Oxford-AstraZeneca COVID-19 vaccine efficacy
Maria Deloria Knoll et al.
LANCET (2021)
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes
Sundareswaran Loganathan et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2021)
Pathology of TB/COVID-19 Co-Infection: The phantom menace
Gabriel Tassi Mousquer et al.
TUBERCULOSIS (2021)
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants
Ana Rita Franco et al.
CELLS (2021)
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects
D. Visca et al.
PULMONOLOGY (2021)
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
Salim S. Abdool Karim et al.
LANCET (2021)
BNT162b2 Vaccine Booster and Mortality Due to Covid-19
Ronen Arbel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Yanjun Zhang et al.
LANCET INFECTIOUS DISEASES (2021)
NIH funding for vaccine readiness before the COVID-19 pandemic
Anthony E. Kiszewski et al.
VACCINE (2021)
Impact of the COVID-19 Pandemic on the Mental Health of Healthcare Workers
Andreas Chatzittofis et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
The BCG Vaccine for COVID-19: First Verdict and Future Directions
Maria Gonzalez-Perez et al.
FRONTIERS IN IMMUNOLOGY (2021)
Lipocalin 2 regulates expression of MHC class I molecules in Mycobacterium tuberculosis-infected dendritic cells via ROS production
Ji-Ae Choi et al.
CELL AND BIOSCIENCE (2021)
Case Report: Development of Miliary Pulmonary Tuberculosis in a Patient with Peritoneal Tuberculosis after COVID-19 Upper Respiratory Tract Infection
Moustafa M. Elziny et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)
Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis
Radha Gopalaswamy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Casirivimab-Imdevimab for Treatment of COVID-19 in Solid Organ Transplant Recipients
Abhay Dhand et al.
TRANSPLANTATION (2021)
Reconcile the debate over protective effects of BCG vaccine against COVID-19
Wei Fu et al.
SCIENTIFIC REPORTS (2021)
The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy
Sylvia Annabel Dass et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons - United States, December 14, 2020-February 14, 2021
Jennifer L. Kriss et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections
Hilal Ahmad Parray et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)
COVID-19 and pulmonary tuberculosis – A diagnostic dilemma
Som Subhro Biswas et al.
Radiology Case Reports (2021)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas et al.
NATURE (2021)
'Super-antibodies' could curb COVID-19 and help avert future pandemics
Elie Dolgin
NATURE BIOTECHNOLOGY (2021)
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
M. Dougan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-I
Yiwen Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Airborne transmission of respiratory viruses
Chia C. Wang et al.
SCIENCE (2021)
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann et al.
CELL REPORTS (2021)
CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection
Yu-Jung Lu et al.
CELL REPORTS (2021)
Current status of therapeutic monoclonal antibodies against SARS-CoV-2
Sanjeev Kumar et al.
PLOS PATHOGENS (2021)
Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
Marianna Rowlands et al.
FRONTIERS IN IMMUNOLOGY (2021)
The SARS-CoV-2 pandemic: A syndemic perspective
Ines Fronteira et al.
ONE HEALTH (2021)
Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19
Raymund R. Razonable et al.
ECLINICALMEDICINE (2021)
Development and application of therapeutic antibodies against COVID-19
Lin Ning et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
mRNA vaccines for COVID-19: what, why and how
Jung Woo Park et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways
Ralf Kircheis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Petra Mlcochova et al.
NATURE (2021)
Variances in BCG protection against COVID-19 mortality: A global assessment
Zouina Sarfraz et al.
JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES (2021)
Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi
Rebecca Nzawa Soko et al.
EMERGING INFECTIOUS DISEASES (2021)
Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection
Catherine Riou et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and Control
Philip C. Hopewell et al.
EMERGING INFECTIOUS DISEASES (2021)
Neutralizing monoclonal antibodies for treatment of COVID-19
Peter C. Taylor et al.
NATURE REVIEWS IMMUNOLOGY (2021)
COVID-19 promoting the development of active tuberculosis in a patient with latent tuberculosis infection: A case report
Mohammed Khayat et al.
RESPIRATORY MEDICINE CASE REPORTS (2021)
Tuberculosis Vaccine Development: Progress in Clinical Evaluation
Suraj B. Sable et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Recent updates on drug resistance in Mycobacterium tuberculosis
R. Singh et al.
JOURNAL OF APPLIED MICROBIOLOGY (2020)
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Hussin A. Rothan et al.
JOURNAL OF AUTOIMMUNITY (2020)
Pathogenesis of COVID-19 from a cell biology perspective
Robert J. Mason
EUROPEAN RESPIRATORY JOURNAL (2020)
COVID-19 in tuberculosis patients: A report of three cases
Guiqing He et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Considering BCG vaccination to reduce the impact of COVID-19
Nigel Curtis et al.
LANCET (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Mild or Moderate Covid-19
Rajesh T. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Economic Consequences of the COVID-19 Outbreak: the Need for Epidemic Preparedness
Anton Pak et al.
FRONTIERS IN PUBLIC HEALTH (2020)
A comprehensive review of COVID-19 characteristics
Hanie Esakandari et al.
BIOLOGICAL PROCEDURES ONLINE (2020)
TCR-like domain antibody against Mycobacterium tuberculosis (Mtb) heat shock protein antigen presented by HLA-A*11 and HLA-A*24
Sylvia Annabel Dass et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Advances in Molecular Diagnosis of Tuberculosis
Emily MacLean et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Case Report: Coronavirus Disease and Pulmonary Tuberculosis in Patients with Human Immunodeficiency Virus: Report of Two Cases
Luis Arthur Brasil Gadelha Farias et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Fatal central nervous system co-infection with SARS-CoV-2 and tuberculosis in a healthy child
Bishara J. Freij et al.
BMC PEDIATRICS (2020)
Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
Evangelos J. Giamarellos-Bourboulis et al.
CELL (2020)
REACTIVATION TB WITH SEVERE COVID-19
Natasha Garg et al.
CHEST (2020)
Vaccines for COVID-19
J. S. Tregoning et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
COVID-19 Clinical Diagnostics and Testing Technology
Cindy H. Chau et al.
PHARMACOTHERAPY (2020)
COVID-19 and TB co-infection - 'Finishing touch in perfect recipe to 'severity' or 'death'
Rohit Kumar et al.
JOURNAL OF INFECTION (2020)
COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management
Md. Farhad Hossain et al.
FRONTIERS IN PHARMACOLOGY (2020)
GeneXpert for the diagnosis of COVID-19 in LMICs
Niaina Rakotosamimanana et al.
LANCET GLOBAL HEALTH (2020)
Selection of a Single Domain Antibody, Specific for an HLA-Bound Epitope of the Mycobacterial Ag85B Antigen
Paola A. Ortega et al.
FRONTIERS IN IMMUNOLOGY (2020)
The case of pulmonary tuberculosis with COVID-19 in an Indian male-a first of its type case ever reported from South Asia
Sankalp Yadav et al.
PAN AFRICAN MEDICAL JOURNAL (2020)
COVID-19 and Tuberculosis Coinfection in a 51-Year-Old Taxi Driver in Mexico City
Jose Arturo Martinez Orozco et al.
AMERICAN JOURNAL OF CASE REPORTS (2020)
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
Wentao Ni et al.
CRITICAL CARE (2020)
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
Jessica J. Manson et al.
LANCET RHEUMATOLOGY (2020)
COVID-19 in a patient with active tuberculosis: A rare case-report
Fahad Faqihi et al.
RESPIRATORY MEDICINE CASE REPORTS (2020)
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
S. Swindells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The global prevalence of latent tuberculosis: a systematic review and meta-analysis
Adam Cohen et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
A Case for Antibodies as Mechanistic Correlates of Immunity in Tuberculosis
Jeffrey Y. Kawahara et al.
FRONTIERS IN IMMUNOLOGY (2019)
Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
Thomas Secher et al.
FRONTIERS IN IMMUNOLOGY (2019)
Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques
Karin Dijkman et al.
NATURE MEDICINE (2019)
Adoptive cellular therapies: the current landscape
Maartje W. Rohaan et al.
VIRCHOWS ARCHIV (2019)
Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study
Partho Roy et al.
LANCET GLOBAL HEALTH (2019)
Tuberculosis and HIV-An Update on the Cursed Duet in Children
Samantha H. -L. Fry et al.
FRONTIERS IN PEDIATRICS (2019)
The Diagnosis and Treatment of Tuberculosis
Isabelle Suarez et al.
DEUTSCHES ARZTEBLATT INTERNATIONAL (2019)
Prevalence of Malaria and TB Coinfection at a National Tuberculosis Treatment Centre in Uganda
Joseph Baruch Baluku et al.
JOURNAL OF TROPICAL MEDICINE (2019)
Generation of a T cell receptor (TCR)-like single domain antibody (sDAb) against a Mycobacterium Tuberculosis (Mtb) heat shock protein (HSP) 16kDa antigen presented by Human Leukocyte Antigen (HLA)-A*02
Sylvia Annabel Dass et al.
MOLECULAR IMMUNOLOGY (2018)
IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals
Fekadu Abebe et al.
PLOS ONE (2018)
Tuberculosis vaccines: Opportunities and challenges
Bingdong Zhu et al.
RESPIROLOGY (2018)
Development of tuberculosis vaccines in clinical trials: Current status
Patricia Mendez-Samperio
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2018)
Antibodies and tuberculosis: finally coming of age?
Hao Li et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Middle East Respiratory Syndrome Coronavirus and Pulmonary Tuberculosis Coinfection: Implications for Infection Control
Sarah H. Alfaraj et al.
INTERVIROLOGY (2017)
The cursed duet today: Tuberculosis and HIV-coinfection
Simon Tiberi et al.
PRESSE MEDICALE (2017)
Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis
Hao Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine
Rafael Prados-Rosales et al.
PLOS PATHOGENS (2017)
PPE38 Protein of Mycobacterium tuberculosis Inhibits Macrophage MHC Class I Expression and Dampens CD8+ T Cell Responses
Lu Meng et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis
Mashael Al-Saeedi et al.
INFECTION AND DRUG RESISTANCE (2017)
Antibody therapies for the prevention and treatment of viral infections
Georgina Salazar et al.
NPJ VACCINES (2017)
TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants
Junyun Lai et al.
SCIENTIFIC REPORTS (2017)
Non-specific effects of vaccines: plausible and potentially important, but implications uncertain
Andrew J. Pollard et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2017)
Clinical Aspects of Adult Tuberculosis
Robert Loddenkemper et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
T cell receptor mimic antibodies for cancer therapy
Leonid Dubrovsky et al.
ONCOIMMUNOLOGY (2016)
Antibiotic resistance mechanisms in M-tuberculosis: an update
Liem Nguyen
ARCHIVES OF TOXICOLOGY (2016)
Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31-April 1, 2016, Tours, France
Guillaume Desoubeaux et al.
MABS (2016)
T-cell activation is an immune correlate of risk in BCG vaccinated infants
Helen A. Fletcher et al.
NATURE COMMUNICATIONS (2016)
Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells
Madleen Giese et al.
ONCOTARGET (2016)
The Progress of Therapeutic Vaccination with Regard to Tuberculosis
Pere-Joan Cardona
FRONTIERS IN MICROBIOLOGY (2016)
T regulatory cells: Achilles' heel of Mycobacterium tuberculosis infection?
Om Parkash et al.
IMMUNOLOGIC RESEARCH (2015)
Tuberculosis and HIV Coinfection
Judith Bruchfeld et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system
L. Guilleminault et al.
JOURNAL OF CONTROLLED RELEASE (2014)
The ongoing challenge of latent tuberculosis
H. Esmail et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities
Catherine Vilcheze et al.
MICROBIOLOGY SPECTRUM (2014)
Antibody-Mediated Immunity against Tuberculosis: Implications for Vaccine Development
Jacqueline M. Achkar et al.
CELL HOST & MICROBE (2013)
The Biology of Mycobacterium Tuberculosis Infection
Giovanni Delogu et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2013)
T-Cell Receptor-Like Antibodies: Targeting the Intracellular Proteome Therapeutic Potential and Clinical Applications
Maya Cohen et al.
ANTIBODIES (2013)
Expression of high-affinity human antibody fragments in bacteria
Romain Rouet et al.
NATURE PROTOCOLS (2012)
Escape from the phagosome: the explanation for MHC-I processing of mycobacterial antigens?
Melanie J. Harriff et al.
FRONTIERS IN IMMUNOLOGY (2012)
Current management options for latent tuberculosis: a review
David Holland et al.
Infection and Drug Resistance (2012)
The immunological life cycle of tuberculosis
Joel D. Ernst
NATURE REVIEWS IMMUNOLOGY (2012)
Mycobacterium tuberculosis: success through dormancy
Martin Gengenbacher et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Pathogenesis, Immunology, and Diagnosis of Latent Mycobacterium tuberculosis Infection
Suhail Ahmad
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Immunosuppressive monoclonal antibodies: current and next generation
D. Focosi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices
Alice Zwerling et al.
PLOS MEDICINE (2011)
The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis
Nitya Krishnan et al.
TUBERCULOSIS (2010)
Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16 kDa protein in a model of progressive pulmonary infection
Yamile Lopez et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Inhaled Drug Delivery for Tuberculosis Therapy
Pavan Muttil et al.
PHARMACEUTICAL RESEARCH (2009)
Prophylactic effect of administration of human gamma globulins in a mouse model of tuberculosis
Nesty Olivares et al.
TUBERCULOSIS (2009)
Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8(+) T-cell response in patients with pulmonary tuberculosis
F. F. Weichold et al.
GENES AND IMMUNITY (2007)
Mechanisms of action of isoniazid
Graham S. Timmins et al.
MOLECULAR MICROBIOLOGY (2006)
The effect of the administration of human gamma globulins in a model of BCG infection in mice
Nesty Olivares et al.
TUBERCULOSIS (2006)
Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice
Evelyn Guirado et al.
MICROBES AND INFECTION (2006)
Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies
S de Vallière et al.
INFECTION AND IMMUNITY (2005)
Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice
E Roy et al.
INFECTION AND IMMUNITY (2005)
Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs
A Williams et al.
IMMUNOLOGY (2004)
A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab′)2 fragment prolong survival of mice infected with Mycobacterium tuberculosis
B Hamasur et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Severe acute respiratory syndrome and pulmonary tuberculosis
JGH Low et al.
CLINICAL INFECTIOUS DISEASES (2004)
Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro
WA Hanekom et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence
I Smith
CLINICAL MICROBIOLOGY REVIEWS (2003)
Failure of the Mycobacterium bovis BCG vaccine:: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis
L Brandt et al.
INFECTION AND IMMUNITY (2002)
How can immunology contribute to the control of tuberculosis?
SHE Kaufmann
NATURE REVIEWS IMMUNOLOGY (2001)
Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery
G Falero-Diaz et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2000)